Radiation enhances the efficacy of EGFR-targeted CAR-T cells against triple-negative breast cancer by activating NF-κB/Icam1 signaling

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)

(2022) Yaya Chu et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma

(2021) Babak Moghimi et al.   Nature Communications

Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells

(2021) Yida Zhang et al.   MOLECULAR CANCER THERAPEUTICS

Strengthening the CAR‐T cell therapeutic application using CRISPR/Cas9 technology

(2021) Muhammad Sadeqi Nezhad et al.   BIOTECHNOLOGY AND BIOENGINEERING

CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1

(2021) Chahrazade Kantari-Mimoun et al.   Cancer Immunology Research

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

(2020) Ozge Saatci et al.   Nature Communications

Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion

(2020) Hong Luo et al.   CLINICAL CANCER RESEARCH

CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?

(2020) Jessica Wagner et al.   MOLECULAR THERAPY

Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice

(2020) Ruixin Sun et al.   MOLECULAR THERAPY

Antitumor efficacy of chimeric antigen receptor T cells against EGFRvIII-expressing glioblastoma in C57BL/6 mice

(2019) Muhua Chen et al.   BIOMEDICINE & PHARMACOTHERAPY

Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells

(2019) Shengmeng Di et al.   Frontiers in Oncology

Breast cancer statistics, 2019

(2019) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors

(2019) Linchun Jin et al.   Nature Communications

Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer

(2018) Amritha Nair et al.   NATURE MEDICINE

CAR T cell immunotherapy for human cancer

(2018) Carl H. June et al.   SCIENCE

CAR T-cell Therapies Produce Durable Remissions

(2018)   Cancer Discovery

seq-ImmuCC: Cell-Centric View of Tissue Transcriptome Measuring Cellular Compositions of Immune Microenvironment From Mouse RNA-Seq Data

(2018) Ziyi Chen et al.   Frontiers in Immunology

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

(2018) Sarwish Rafiq et al.   NATURE BIOTECHNOLOGY

Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bi-targeted Chimeric Antigen Receptor T Cell

(2018) Hua Jiang et al.   Cancer Immunology Research

Expression of MT4-MMP, EGFR and RB in triple negative breast cancer strongly sensitizes tumors to erlotinib and palbociclib combination therapy

(2018) Pierre Foidart et al.   CLINICAL CANCER RESEARCH

Best Practices for Preparing a Single Cell Suspension from Solid Tissues for Flow Cytometry

(2018) Andrew Reichard et al.   CYTOMETRY PART A

Immunological therapy: A novel thriving area for triple-negative breast cancer treatment

(2018) Xiangyu Wang et al.   CANCER LETTERS

Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy

(2017) P. S. Chowdhury et al.   JOURNAL OF INTERNAL MEDICINE

FDA Approves Second CAR T-cell Therapy

(2017)   Cancer Discovery

A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer

(2017) Paul Savage et al.   Cell Reports

Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways

(2017) et al.   Cancers

The regulation of transendothelial migration: new knowledge and new questions

(2015) William A. Muller   CARDIOVASCULAR RESEARCH

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling

(2013) A Ko et al.   CELL DEATH AND DIFFERENTIATION

Targeting the EGFR signaling pathway in cancer therapy

(2012) Parthasarathy Seshacharyulu et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Cancer and Radiation Therapy: Current Advances and Future Directions

(2012) Rajamanickam Baskar et al.   International Journal of Medical Sciences

Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma

(2012) D Kesanakurti et al.   ONCOGENE

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

(2010) Carol Kilkenny et al.   PLOS BIOLOGY

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer

(2009) B. Corkery et al.   ANNALS OF ONCOLOGY

Lymphocyte Crawling and Transendothelial Migration Require Chemokine Triggering of High-Affinity LFA-1 Integrin

(2009) Ziv Shulman et al.   IMMUNITY